nach oben

Erschienen in:

20.08.2018 | Pankreaszysten | fortbildung

Pankreaszysten — Therapie

Management bei Risiko einer malignen Entartung

verfasst von: Florian Scheufele, Arzt, Prof. Dr. med. Helmut Friess

Erschienen in: Gastro-News | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Nach Entdeckung einer Pankreaszyste ist es wichtig, diese Zyste näher einzuordnen und das weitere Vorgehen entsprechend zu planen. Bei einigen Zysten ist keine Therapie notwendig, manche bedürfen einer systematischen Überwachung und wieder andere sollten reseziert werden.

Zhang, X.M., et al., Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology, 2002. 223(2): p. 547–53.CrossRefPubMed

Lee, K.S., et al., Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol, 2010. {nv105 (9)}: p. 2079–84.

Fernandez-del Castillo, C., et al., Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg, 2003. 138 (4)}: p. 427–3; discussion 433–4.

Hammel, P.R., et al., Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel-Lindau. Gastroenterology, 2000. 119(4): p. 1087–95.CrossRefPubMed

Banks, P.A., et al., Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut, 2013. 62(1): p. 102–11.CrossRefPubMed

Kosmahl, M., et al., Mucinous nonneoplastic cyst of the pancreas: a novel nonneoplastic cystic change? Mod Pathol, 2002. 15(2): p. 154–8.CrossRefPubMed

Tseng, J.F., et al., Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg, 2005. 242(3): p. 413–9; discussion 419–21.PubMedPubMedCentral

Brugge, W.R., Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol, 2015. 6(4): p. 375–88.PubMedPubMedCentral

Reddy, R.P., et al., Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol, 2004. 2(11): p. 1026–31.CrossRefPubMed

10.

Mergener, K., S.E. Detweiler, and L.W. Traverso, Solid pseudopapillary tumor of the pancreas: diagnosis by EUS-guided fine-needle aspiration. Endoscopy, 2003. 35(12): p. 1083–4.CrossRefPubMed

11.

Scheiman, J.M., J.H. Hwang, and P. Moayyedi, American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology, 2015. 148(4): p. 824–48 e22.CrossRefPubMed

12.

European Study Group on Cystic Tumours of the, P., European evidence-based guidelines on pancreatic cystic neoplasms. Gut, 2018. 67(5): p. 789–804.CrossRef

13.

Romics, L., Jr., et al., Solid pseudopapillary neoplasm of the pancreas—proposed algorithms for diagnosis and surgical treatment. Langenbecks Arch Surg, 2010. 395(6): p. 747–55.CrossRefPubMed

14.

Waters, J.A., et al., CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg, 2008. 12(1): p. 101–9.CrossRefPubMed

15.

Kamata, K., et al., Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy, 2016. 48(1): p. 35–41.PubMed

16.

Brugge, W.R., et al., Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology, 2004. 126(5): p. 1330–1336.CrossRefPubMed

17.

Grutzmann, R., et al., Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist, 2010. 15(12): p. 1294–309.CrossRefPubMedPubMedCentral

18.

Cizginer, S., et al., Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas, 2011. 40(7): p. 1024–8.CrossRefPubMed

19.

Jang, J.Y., et al., Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg, 2017. 266(6): p. 1062–1068.CrossRefPubMed

20.

Singhi, A.D., et al., Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res, 2014. 20(16): p. 4381–9.CrossRefPubMed

21.

Tanaka, M., et al., International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology, 2006. 6(1–2): p. 17–32.CrossRefPubMed

22.

Tanaka, M., et al., International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology, 2012. 12(3): p. 183–97.CrossRefPubMed

23.

Del Chiaro, M., et al., European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis, 2013. 45(9): p. 703–11.CrossRefPubMed

24.

Gan, S.I., et al., Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointestinal Endoscopy, 2005. 61(6): p. 746–752.CrossRefPubMed

25.

Oh, H.C., et al., New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc, 2008. 67(4): p. 636–42.CrossRefPubMed

26.

Oh, H.C., et al., Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology, 2011. 140(1): p. 172–9.CrossRefPubMed

27.

Fernandez-Del Castillo, C., EUS treatment of pancreatic cysts: let’s keep the alcohol (and the chemotherapy) locked in the cupboard. Gastroenterology, 2011. 140(7): p. 2144–5.CrossRefPubMed

28.

Gomez, V., et al., EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video). Gastrointest Endosc, 2016. 83(5): p. 914–20.CrossRefPubMed

29.

Park, J.K., et al., Clinical Outcomes of Endoscopic Ultrasonography-Guided Pancreatic Cyst Ablation. Pancreas, 2016. 45(6): p. 889–94.CrossRefPubMed

30.

Del Chiaro, M., et al., Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol, 2017. 24(4): p. 1120–1126.CrossRefPubMed

31.

Lawrence, S.A., et al., Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution. Ann Surg, 2017. 266(3): p. 536–544.CrossRefPubMed

32.

Tian, X., et al., Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: a retrospective cohort study. Int J Surg, 2015. 13: p. 49–53.CrossRefPubMed

33.

Nilsson, L.N., et al., Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature. Pancreatology, 2016. 16(6): p. 1028–1036.CrossRefPubMed

34.

Kim, M.J., et al., Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy. Br J Surg, 2014. 101(10): p. 1266–71.CrossRefPubMed

35.

Wang, W.B., et al., Solid pseudopapillary tumor of the pancreas with liver metastasis: Clinical features and management. Eur J Surg Oncol, 2014. 40(11): p. 1572–7.CrossRefPubMed

36.

Arvanitakis, M., et al., Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology, 2004. 126(3): p. 715–723.CrossRefPubMed

37.

Cui, M.L., et al., Incidence, risk factors and clinical course of pancreatic fluid collections in acute pancreatitis. Dig Dis Sci, 2014. 59(5): p. 1055–62.CrossRefPubMed

38.

Committee, A.S.o.P., et al., The role of endoscopy in the diagnosis and treatment of inflammatory pancreatic fluid collections. Gastrointest Endosc, 2016. 83(3): p. 481–8.CrossRef

39.

Hookey, L.C., et al., Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc, 2006. 63(4): p. 635–43.CrossRefPubMed

40.

Baril, N.B., et al., Does an infected peripancreatic fluid collection or abscess mandate operation? Annals of Surgery, 2000. 231(3): p. 361–367.CrossRefPubMedPubMedCentral

41.

Freeny, P.C., et al., Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. AJR Am J Roentgenol, 1998. 170(4): p. 969–75.CrossRefPubMed

42.

Rodriguez, J.R., et al., Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg, 2008. 247(2): p. 294–9.CrossRefPubMedPubMedCentral

43.

Krautz, C., et al., Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany. Ann Surg, 2018. 267(3): p. 411–417.CrossRefPubMed

44.

Nimptsch, U., et al., Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated. Ann Surg, 2016. 264(6): p. 1082–1090.CrossRefPubMed

Titel: Pankreaszysten — Therapie
Management bei Risiko einer malignen Entartung
verfasst von: Florian Scheufele, Arzt
Prof. Dr. med. Helmut Friess
Publikationsdatum: 20.08.2018
Verlag: Springer Medizin
Schlagwort: Pankreaszysten
Erschienen in: Gastro-News / Ausgabe 4/2018
Print ISSN: 1869-1005
Elektronische ISSN: 2520-8667
DOI: https://doi.org/10.1007/s15036-018-0419-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Management bei Risiko einer malignen Entartung

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Zinplava® — reduziert das Rekurrenzrisiko einer Clostridium-difficile-Infektion

G-POEM als neue endoskopische Behandlungsmethode

Modulation der Immunreaktion kann Organdysfunktionen bei ACLF reduzieren

Der Traum von einer effektiven Medikation

Krebsrisiko bei akuter Pankreatitis

Mikroskopische Kolitis gehört zum CED-Spektrum

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin